---
figid: PMC3303581__JAR2012-251217.001
figlink: /pmc/articles/PMC3303581/figure/fig1/
number: F1
caption: Myostatin signals through the ActRIIB-ALK4/5 heterodimer activate Smad2/3
  with blocking of MyoD transactivation in an autoregulatory feedback loop. In addition,
  Smad3 sequesters MyoD in the cytoplasm to prevent it from entering the nucleus and
  activating the stem cell population. Recent findings [, ] have suggested that myostatin-Smad
  pathway inhibits protein synthesis probably due to blocking the functional role
  of Akt. Supplementation with ursolic acid upregulates the amount of IGF-I and insulin
  and then stimulates protein synthesis by activating Akt/mTOR/p70S6K pathway [].
  Treatment with ACE inhibitor also enhances IGF-I level in muscle. Amino acid supplementation
  enhances protein synthesis by stimulating mTOR []. Akt blocks the nuclear translocation
  of FOXO to inhibit the expression of Atrogin-1 and MuRF1 and the consequent protein
  degradation. Proteasome inhibitors combat the ubiquitin-proteasome signaling activated
  by these atrogenes. In cachexic muscle, supplementation with EPA downregulates the
  amount of TNF-α and NF-κB [, ]. Endurance exercise increases the amount of PGC-1α
  through calcineurin- or CaMK-dependent signaling []. Both activated PGC-1α, and
  cyclophilin inhibitor protects several mitochondrial disorders (apoptosis, oxidative
  damage, etc.) elicited by the increase in NF-κB and Bax and/or the decrease in Bcl-2
  in senescent muscle. ACE; angiotensin-converting enzyme, ActRIIB; activin receptor
  IIB, ALK4/5; activin-like kinase 4/5, CaMK; calmodulin kinase, eIF4E; eukaryotic
  initiation factor 4E, EPA; eicosapentaenoic acid, FOXO; Forkhead box O, IGF-I; insulin-like
  growth factor-I, IKK; inhibitor of κB kinase, mTOR; mammalian target of rapamycin,
  MuRF1; muscle ring-finger protein 1, NF-κB; nuclear factor of kappa B, PGC-1α; peroxisome
  proliferator-activated receptor γ coactivator α, PI3-K; phosphatidylinositol 3-kinase,
  Rheb; Ras homolog enriched in brain, TNF-α; tumor nectosis factor-α, TORC1; a component
  of TOR-signaling complex 1.
pmcid: PMC3303581
papertitle: Novel Intriguing Strategies Attenuating to Sarcopenia.
reftext: Kunihiro Sakuma, et al. J Aging Res. 2012;2012:251217.
pmc_ranked_result_index: '114222'
pathway_score: 0.944156
filename: JAR2012-251217.001.jpg
figtitle: Myostatin signals through the ActRIIB-ALK4/5 heterodimer activate Smad2/3
  with blocking of MyoD transactivation in an autoregulatory feedback loop
year: '2012'
organisms:
- Homo sapiens
ndex: ee072109-df00-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3303581__JAR2012-251217.001.html
  '@type': Dataset
  description: Myostatin signals through the ActRIIB-ALK4/5 heterodimer activate Smad2/3
    with blocking of MyoD transactivation in an autoregulatory feedback loop. In addition,
    Smad3 sequesters MyoD in the cytoplasm to prevent it from entering the nucleus
    and activating the stem cell population. Recent findings [, ] have suggested that
    myostatin-Smad pathway inhibits protein synthesis probably due to blocking the
    functional role of Akt. Supplementation with ursolic acid upregulates the amount
    of IGF-I and insulin and then stimulates protein synthesis by activating Akt/mTOR/p70S6K
    pathway []. Treatment with ACE inhibitor also enhances IGF-I level in muscle.
    Amino acid supplementation enhances protein synthesis by stimulating mTOR [].
    Akt blocks the nuclear translocation of FOXO to inhibit the expression of Atrogin-1
    and MuRF1 and the consequent protein degradation. Proteasome inhibitors combat
    the ubiquitin-proteasome signaling activated by these atrogenes. In cachexic muscle,
    supplementation with EPA downregulates the amount of TNF-α and NF-κB [, ]. Endurance
    exercise increases the amount of PGC-1α through calcineurin- or CaMK-dependent
    signaling []. Both activated PGC-1α, and cyclophilin inhibitor protects several
    mitochondrial disorders (apoptosis, oxidative damage, etc.) elicited by the increase
    in NF-κB and Bax and/or the decrease in Bcl-2 in senescent muscle. ACE; angiotensin-converting
    enzyme, ActRIIB; activin receptor IIB, ALK4/5; activin-like kinase 4/5, CaMK;
    calmodulin kinase, eIF4E; eukaryotic initiation factor 4E, EPA; eicosapentaenoic
    acid, FOXO; Forkhead box O, IGF-I; insulin-like growth factor-I, IKK; inhibitor
    of κB kinase, mTOR; mammalian target of rapamycin, MuRF1; muscle ring-finger protein
    1, NF-κB; nuclear factor of kappa B, PGC-1α; peroxisome proliferator-activated
    receptor γ coactivator α, PI3-K; phosphatidylinositol 3-kinase, Rheb; Ras homolog
    enriched in brain, TNF-α; tumor nectosis factor-α, TORC1; a component of TOR-signaling
    complex 1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CAMK2A
  - AKT1
  - RPS6KB2
  - AKT2
  - PPP3R1
  - PPIL3
  - PIK3R4
  - FOXO4
  - PPP3CC
  - PPP3CB
  - RHEB
  - ACE
  - CAMK1
  - PPIL2
  - PPIL6
  - PIK3R6
  - TNF
  - PPIAL4C
  - PPIL4
  - FOXO1
  - FOXO3
  - SMAD3
  - MYOD1
  - RPS6KB1
  - PPIE
  - PPIH
  - PPP3R2
  - ACVR2B
  - ACVR1B
  - FBXO32
  - MTOR
  - FOXO6
  - IKBKG
  - PPP3CA
  - IGF1
  - PPIF
  - CWC27
  - PIK3R3
  - CAMK1G
  - PPIAL4A
  - PPIL1
  - AKT3
  - PIK3CG
  - CAMK4
  - PPIAL4G
  - PPID
  - PIK3R5
  - PPIA
  - PPWD1
  - SMAD2
  - CAMK1D
  - CAMK2D
  - CHUK
  - IKBKB
  - PIK3CD
  - CAMK2G
  - CAMK2B
  - PIK3CB
  - PPIC
  - PPIB
  - PIK3CA
  - Ursolic acid
  - Cancer
genes:
- word: CAMK
  symbol: CAMK
  source: bioentities_symbol
  hgnc_symbol: CAMK2A
  entrez: '815'
- word: H|Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: H|Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R1
  entrez: '5534'
- word: Cyclophilin
  symbol: Cyclophilin
  source: bioentities_symbol
  hgnc_symbol: PPIL3
  entrez: '53938'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CC
  entrez: '5533'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CB
  entrez: '5532'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: ACE
  symbol: ACE
  source: hgnc_symbol
  hgnc_symbol: ACE
  entrez: '1636'
- word: CAMK
  symbol: CAMK
  source: bioentities_symbol
  hgnc_symbol: CAMK1
  entrez: '8536'
- word: Cyclophilin
  symbol: Cyclophilin
  source: bioentities_symbol
  hgnc_symbol: PPIL2
  entrez: '23759'
- word: Cyclophilin
  symbol: Cyclophilin
  source: bioentities_symbol
  hgnc_symbol: PPIL6
  entrez: '285755'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: Cyclophilin
  symbol: Cyclophilin
  source: bioentities_symbol
  hgnc_symbol: PPIAL4C
  entrez: '653598'
- word: Cyclophilin
  symbol: Cyclophilin
  source: bioentities_symbol
  hgnc_symbol: PPIL4
  entrez: '85313'
- word: (TNF-a,
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: P-Smad2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: MyoD
  symbol: MYOD
  source: hgnc_alias_symbol
  hgnc_symbol: MYOD1
  entrez: '4654'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: Cyclophilin
  symbol: Cyclophilin
  source: bioentities_symbol
  hgnc_symbol: PPIE
  entrez: '10450'
- word: Cyclophilin
  symbol: Cyclophilin
  source: bioentities_symbol
  hgnc_symbol: PPIH
  entrez: '10465'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R2
  entrez: '5535'
- word: ActRIIB||
  symbol: ActR-IIB
  source: hgnc_alias_symbol
  hgnc_symbol: ACVR2B
  entrez: '93'
- word: ALK4/5)
  symbol: ALK4
  source: hgnc_alias_symbol
  hgnc_symbol: ACVR1B
  entrez: '91'
- word: Atrogin-1
  symbol: ATROGIN1
  source: hgnc_alias_symbol
  hgnc_symbol: FBXO32
  entrez: '114907'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CA
  entrez: '5530'
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: Cyclophilin
  symbol: Cyclophilin
  source: bioentities_symbol
  hgnc_symbol: PPIF
  entrez: '10105'
- word: Cyclophilin
  symbol: Cyclophilin
  source: bioentities_symbol
  hgnc_symbol: CWC27
  entrez: '10283'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: CAMK
  symbol: CAMK
  source: bioentities_symbol
  hgnc_symbol: CAMK1G
  entrez: '57172'
- word: Cyclophilin
  symbol: Cyclophilin
  source: bioentities_symbol
  hgnc_symbol: PPIAL4A
  entrez: '653505'
- word: Cyclophilin
  symbol: Cyclophilin
  source: bioentities_symbol
  hgnc_symbol: PPIL1
  entrez: '51645'
- word: H|Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: CAMK
  symbol: CAMK
  source: bioentities_symbol
  hgnc_symbol: CAMK4
  entrez: '814'
- word: Cyclophilin
  symbol: Cyclophilin
  source: bioentities_symbol
  hgnc_symbol: PPIAL4G
  entrez: '644591'
- word: Cyclophilin
  symbol: Cyclophilin
  source: bioentities_symbol
  hgnc_symbol: PPID
  entrez: '5481'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Cyclophilin
  symbol: Cyclophilin
  source: bioentities_symbol
  hgnc_symbol: PPIA
  entrez: '5478'
- word: Cyclophilin
  symbol: Cyclophilin
  source: bioentities_symbol
  hgnc_symbol: PPWD1
  entrez: '23398'
- word: P-Smad2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: CAMK
  symbol: CAMK
  source: bioentities_symbol
  hgnc_symbol: CAMK1D
  entrez: '57118'
- word: CAMK
  symbol: CAMK
  source: bioentities_symbol
  hgnc_symbol: CAMK2D
  entrez: '817'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: CAMK
  symbol: CAMK
  source: bioentities_symbol
  hgnc_symbol: CAMK2G
  entrez: '818'
- word: CAMK
  symbol: CAMK
  source: bioentities_symbol
  hgnc_symbol: CAMK2B
  entrez: '816'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Cyclophilin
  symbol: Cyclophilin
  source: bioentities_symbol
  hgnc_symbol: PPIC
  entrez: '5480'
- word: Cyclophilin
  symbol: Cyclophilin
  source: bioentities_symbol
  hgnc_symbol: PPIB
  entrez: '5479'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
chemicals:
- word: Ursolic acid
  source: MESH
  identifier: C005466
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3303581__F1
redirect_from: /figures/PMC3303581__F1
figtype: Figure
---
